Resource
Dear Reader
A Message from the President
Scientific & Clinical
American Society of Hematology 47th Annual Meeting
2006 IMF Brian D. Novis Research Grant Awards
CDC Grant Award Update…
Resource
Dear Reader
A Message from the President
Scientific & Clinical
Pathogenisis and Maintenance of Multiple Myeloma
Making Clinical Trials More Patient-Friendly
MOZOBIL, a Potential New Agent for Stem Cell Harvesting…
Resource
Dear Reader
A Message from the President
Scientific & Clinical
IMF Launches Bank On a Cure
Revlimid Where Do We Stand?
Bortezomib as Treatment as MM: Analysis of Efficacy and Toxicity…
Resource
Dear Reader
A Message from the President
Scientific & Clinical
Program Highlights from the 10th International Workshop in Myeloma
2005 Brian D. Novis Research Grants
Update on Lenalidomide (CC-…
Resource
This research focuses on unifying a multiple myeloma staging system around the world called the International Staging System (ISS). Information was taken from 10,750 myeloma patients previously untreated from North America, Asia, and Europe. The results of testing three different assessments for…
Resource
Dear Reader
A Message from the President
Scientific & Clinical
IMF Celebrates Landmark Success of 2004
Medicare Reform Targets Cancer for Cost Savings
New Developments in Multiple Myeloma…
Resource
Message from IMF President
Why Bank On A Cure®?
Treating Multiple Myeloma: The Little Rock Approach
The Genetics of Multiple Myeloma
Drug Resistance: Overcoming Multiple Myeloma Drug Resistance by Inhibiting the…
Resource
Message from IMF President
Advocacy Update: Congress Adjourns with Support for Myeloma Community
ASH 2003: An Avalanche of New Information
News & Notes
2004 Brian D. Novis Research Grant Awards
…
Resource
Saluting an Incredible Human Being:
Dr. Robert A. Kyle Receives Lifetime Achievement Award
Myeloma Patients and Oncology Nurses to Benefit from IMF/Millennium Collaboration
The IMF Visits Italy and France
Early studies…
Resource
These consensus guidelines have been compiled with input from the Scientific Advisors of the International Myeloma Foundation. Their production involved several steps including:
A 3-day Scientific Advisors meeting, during which each specific area was presented and discussed (May 2002…
Resource
Dear Reader
Ask the Expert
The Pathogenesis and Treatment of Multiple Myeloma Bone Disease
The Good, the Bad, and the Ugly of Cancer Public Policy
IMFer Profile
Terry Herman Shares…
Resource
Dear Reader
FDA Approves VELCADE® for the Treatment of Relapsed and Refractory Multiple Myeloma
Profile Interview: Julian Adams, Ph.D.
Life Lessons from a Politician
Myeloma Update: Overview of the 9th…
Resource
Report from the Los Angeles IMF Patient & Family Interactive Seminar/strong>
Dear Reader
Ask the Expert: Staying Well During Chemotherapy
Indiana University Cancer Research Center…
Resource
Dear Reader
Ribbon of Hope — Making a World of Difference
IMF 12th Anniversary Gala
Did You Know?
Immunizations in myeloma patients
The Gift of Good Nutrition
Ask the…
Resource
Dear Reader
IMF Support Group Leaders’ Retreat 2002
Friends We Never Hoped to Meet
Ask the Expert: Dr. Steve Schey Answers Your Questions
Legal Assistance for the Cancer Patient…
Resource
IMF World Events
Dear Reader
Neuropathy and Monoclonal Gammopathy
Developing the Second Generation Myeloma Chip
PS-341: The Patient Experience
Multiple Musicians Against Multiple Myeloma…
Resource
Dear Reader
IMF President Susie Novis Testifies Before Senate Appropriations Subcommitee
OVAC 2002 Advocacy Day Senate Hearing: Oral Testimony of Susie Novis
NCI Director Andrew von Eschenbach's Speech Highlights Patient-Family…
Resource
The Importance of Knowing the Potential Outcome: Role for the new International Prognostic Index (IPI)
Ask the Experts: Genetic Testing to Determine The Cause and Outcome of Myeloma
Bench to the Bedside: Is it a Myth?
After Any Diagnosis
Gala 2002 Honoree: Daniel E.…
Resource
Dear Reader
The IMF Presents: Myeloma Matrix
Ask the Experts: Infection in Multiple Myeloma
Book Review: Living Proof
IMFer Profile: Lee Grayson…
Resource
Autologous Hematopoietic Stem Cell Transplantation by J-L Harousseau
Bone Marrow and Peripheral Blood Stem Cell Transplantation by G. Gahrton
Myeloma Today Profile: Dr. Joan Blade and Prof. Jesus San Miguel
Stem Cell…
News Article
Dr. Wee Joo Chng to Receive Asian Myeloma Network Distinguished Service Award at the 10th AMN Summit in ShanghaiSHANGHAI, Oct. 16, 2026 -- The International Myeloma Foundation (IMF) will be holding the Asian Myeloma Network (AMN) awards ceremony on Saturday, October 17…
Videos
A New Multiple Myeloma Drug Is Here: What to Know About ZenbexusA new FDA-approved treatment for relapsed multiple myeloma is here. Dr. Joseph Mikhael of the International Myeloma Foundation explains Zenbexus (iberdomide), the first approved CELMoD drug, including who may be eligible, how it works…
Blog post
One Mom’s Story of Living with Myeloma While Raising Two Children In 2013, Sue Massey received a diagnosis of monoclonal gammopathy of undetermined significance (MGUS). She was married at the time and had a four-year-old daughter. Because she had a young child…
Blog post
A summary of some notable key multiple myeloma research from August-September 2026 Scope and Methodology This week’s blog summarizes key multiple myeloma research published in several peer-reviewed publications and medical journals from August-…
Page
Resources to Share With Your PatientsWhether someone is newly diagnosed, exploring treatment options, or managing life with myeloma, the IMF offers resources to help patients and care partners better understand their care and find the support they need.Explore the resources below to find…
Blog post
Coping with Myeloma: Insights from a Social Worker The IMF's Associate Director of Support Groups, Katie Atkins, MSW, LCSW, LCAS, CCS, OSW-C, led a session on "The Unseen Impact of Myeloma" on March 13, 2026, at the IMF Patient & Family Seminar in Boca Raton, Florida. Katie focused…
Blog post
Son Faces Long-Distance Caregiving Challenges to Help Father with Cancer When Arpit Kapdi left Mumbai for the United States, he never imagined that one day he would be helping save his father's life from nearly 8,000 miles away.An engineer living in Detroit since 2015, Arpit returns to India…
News Article
Positive topline results from Phase 3 EXCALIBER-RRMM trial showed significant improvement in the dual-primary endpoint of progression-free survival (PFS) in ZDd combination vs standard of care (DVd). On Thursday, October 8, Bristol Myers Squibb (BMS) announced positive topline results from the…
Videos
Myeloma Blood Tests Explained: CBC, M Spike & Light Chains | Multiple Myeloma in a MinuteThose with multiple myeloma have a lot of lab work, but which blood tests matter most? In this Myeloma in a Minute video, IMF Medical Advisor Dr. Joseph Mikhael breaks down the three key types of blood…
Videos
Replay the Facebook Q&A with Dr. Urvi Shah | September Blood Cancer Awareness Month #KnowMyelomaDr. Urvi Shah joined us live on Facebook on Thursday, September 10 at 4:00 p.m. PT / 7:00 p.m. ETDr. Shah answered questions from the comments and discussed what patients, care partners, and families…
Blog post
Author insights from iStopMM Project team members on the newest published results from the iStopMM study. This year, iStopMM (Iceland Screens, Treats, or Prevents Multiple Myeloma) will be celebrating its 10th year since its start. The study has had a big impact on the field of myeloma…
Blog post
A summary of some notable key multiple myeloma research from July-August 2026 Scope and Methodology This week’s blog summarizes key multiple myeloma research published in several peer-reviewed publications and medical journals from July-August 2026. Content…
Blog post
The Road to the Cure: 2026 Marks the Closest the Myeloma Community Has Come to the Finish Line The International Myeloma Society (IMS) convened for a Myeloma Cure Summit in March 2026. The International Myeloma Foundation (IMF) was there, and our experts gleaned insights on how to define cure…
Blog post
Top highlights from Day One of the 12th Annual Global Myeloma Action (GMAN) Summit held in Stockholm, Sweden.The International Myeloma Foundation’s (IMF) 2026 Global Myeloma Action Network Summit took place from June 5-7, 2026, in Stockholm, Sweden — bringing together myeloma patient organizations…
Videos
Why Don’t We Treat MGUS? What MGUS Means for Multiple Myeloma Risk If MGUS can become multiple myeloma, why don't doctors treat it? IMF Medical Advisor Dr. Joseph Mikhael explains why MGUS is typically not treated and why routine monitoring is important.Learn what MGUS means, why most people…
Blog post
IMF Chairperson of the Board Dr. S. Vincent Rajkumar answers updated FAQs on newly diagnosed myeloma for 2026. In this week’s blog, International Myeloma Foundation (IMF) Chairperson of the Board S. Vincent Rajkumar, MD (Mayo Clinic — Rochester, MN) provides answers to updated…
Blog post
2026 ASCO and EHA: Top 10 Research Abstracts International meetings highlight advances in myeloma By Dr. Joseph Mikhael, IMF Medical Advisor Three of the most important annual medical meetings in myeloma take place each summer. This year, the American Society of…
Blog post
A summary of some notable key multiple myeloma research from June-July 2026 Scope and Methodology This week’s blog summarizes key multiple myeloma research published in several peer-reviewed publications and medical journals from June-July 2026. Content was…
News Article
Riding with PurposeEric Blackburn’s commitment to the IMFBy Simona Grace, IMF Senior Director, DevelopmentWhen Eric Blackburn signed up for the International Myeloma Foundation’s Iceland Cycling Expedition, he committed to a cause that had become deeply personal.A Gulf War veteran…
Blog post
Jim Omel, MD: When the Doctor Becomes the Patient When the doctor becomes the patient, the meaning of living well with myeloma is amplified. Jim Omel, MD, had been a family physician for 25 years, and his favorite part of his career was having delivered more than 1,000 babies. Getting…
News Article
At the end of every month, the International Myeloma Foundation Newsroom will feature a wrap-up of some of the most fascinating studies about multiple myeloma from medical journals. Here is the September 2026 edition.The IMF team of medical editors has provided overviews of key studies. We…
Blog post
The IMF Conference Series talks about key myeloma research from ASCO, IMWG, and EHA 2026 In this IMF Conference Series webinar, International Myeloma Foundation (IMF) President & CEO Heather Cooper Ortner, along with highly esteemed myeloma expert panelists: IMF Chairperson of the Board Dr…
Blog post
Navigating Insurance and Medical Bills Key Health Insurance Terms to KnowThese common terms can help you better understand your coverage:Monthly premium: what you pay each month to have coverage – you pay these…
Blog post
Top myeloma clinicians, Dr. Joseph Mikhael, an IMF Medical Advisor and Professor in the Applied Cancer Research and Drug Discovery Division at TGen at the City of Hope, and Dr. Ola Landgren of the University of Miami, Sylvester Comprehensive Cancer Center, discuss five key topics in the field of…
Blog post
A summary of some notable key multiple myeloma research from May-June 2026 Scope and Methodology This week’s blog summarizes key multiple myeloma research published in several peer-reviewed publications and medical journals from May-June 2026. Content was…
News Article
Myeloma May Be Curable for Some. Experts Are Working to Arrive at a Definition for Cure. September 24, 2026 — At the 23rd International Myeloma Society Annual Meeting & Exposition, international experts are working toward…
News Article
Updated NCCN Myeloma Guidelines include NDMM treatment updates, changes to treatment strategies for RRMM, and MRD testing (EDITOR'S NOTE: This news article was medically reviewed by Joseph Mikhael, MD, MEd, FRCPC, FACP, FASCO, on September 23, 2026. The article reflects medical guidance…
Videos
Does Remission Mean You're Cured? What It Means in Multiple MyelomaIf your multiple myeloma is in remission, does that mean you're cured? IMF Medical Advisor Dr. Joseph Mikhael explains what remission means in multiple myeloma and why remission and cure are not the same thing.Learn about the…
Blog post
One Lyric at a Time: How Oya Gilbert Turned a Delayed Myeloma Diagnosis into Advocacy The Mountain Before the DiagnosisFifty-five-year-old Oya Gilbert climbed his own mountain before being diagnosed with multiple myeloma. From 2015–2017, Oya experienced such symptoms as extreme fatigue,…
Blog post
Top Takeaways from the IMF Living Well with Myeloma Webinar: Movement for Myeloma Patients and Care Partners Learn why movement and exercise are on track to become the standard of care for myeloma patients and care partners from this March 10 IMF Living Well with Myeloma (LWM) Webinar. …